Pasko Deborah A, Mottes Theresa A, Mueller Bruce A
College of Pharmacy, University of Michigan, Michigan, USA.
Pediatr Nephrol. 2003 Nov;18(11):1177-83. doi: 10.1007/s00467-003-1258-2. Epub 2003 Oct 2.
In critically ill children weighing <10 kg, it is necessary to use blood as a priming solution for the extracorporeal continuous renal replacement therapy (CRRT) circuit before initiating CRRT to prevent hemodilution and maintain adequate oxygenation. However, blood bank blood usually contains supra-physiological electrolyte concentrations and a non-physiological acid-base balance that may exacerbate the patient's condition. The objective of this trial was to develop a simple protocol to pre-treat blood bank-derived blood to yield a more physiological blood priming solution. Expired human blood in a recirculating in vitro CRRT circuit was dialyzed prior to the initiation of CRRT using a physiological dialysate solution. Serial blood samples were assessed for electrolyte and pH content. Regimens using maximal blood flow rates (180-200 ml/min) and aggressive dialysate flow rates (33-42 ml/min) were able to correct severely hyperkalemic and acidemic blood within 7.5 min. Initially elevated blood potassium concentrations >20 mEq/l were normalized to below 5 mEq/l within 7.5 min of dialysis in all cases. Blood bank-derived blood can be "conditioned" quickly to physiological pH and electrolyte concentrations using these simple pre-dialysis regimens. Unlike some blood preparation regimens that have been published, the technique used in this trial requires no special equipment or added medications that are not already used in CRRT.
在体重小于10kg的危重症儿童中,在启动体外持续肾脏替代治疗(CRRT)之前,有必要使用血液作为CRRT回路的预充溶液,以防止血液稀释并维持足够的氧合。然而,血库血液通常含有超生理浓度的电解质和非生理酸碱平衡,这可能会加重患者的病情。本试验的目的是制定一个简单的方案,对血库来源的血液进行预处理,以产生更符合生理的血液预充溶液。在体外循环的CRRT回路中,使用生理透析液在启动CRRT之前对过期的人血进行透析。对系列血样进行电解质和pH值含量评估。使用最大血流量(180 - 200ml/min)和积极的透析液流速(33 - 42ml/min)的方案能够在7.5分钟内纠正严重高钾血症和酸血症的血液。在所有病例中,最初高于20mEq/l的血钾浓度在透析7.5分钟内恢复正常至5mEq/l以下。使用这些简单的透析前方案,血库来源的血液可以迅速“调节”至生理pH值和电解质浓度。与一些已发表的血液制备方案不同,本试验中使用的技术不需要特殊设备,也不需要添加CRRT中尚未使用的药物。